The ins and outs of p53

Moving proteins between cellular locations is proving to be a tightly regulated process, and provides an important mechanism for controlling protein function. The tumour-suppressor protein p53 has been shown to use microtubules to aid nuclear localization, a finding that raises interesting questions about the action of microtubule-disrupting chemotherapeutic drugs.

[1]  M. Lohrum,et al.  Regulation and activation of p53 and its family members , 1999, Cell Death and Differentiation.

[2]  Longgui Wang,et al.  The effect of antimicrotubule agents on signal transduction pathways of apoptosis: a review , 1999, Cancer Chemotherapy and Pharmacology.

[3]  C. Prives,et al.  The p53 pathway , 1999, The Journal of pathology.

[4]  M. Peifer,et al.  Teaching tumour suppressors new tricks , 2000, Nature Cell Biology.

[5]  U. Moll,et al.  Cytoplasmically “Sequestered” Wild Type p53 Protein Is Resistant to Mdm2-mediated Degradation* , 1999, The Journal of Biological Chemistry.

[6]  J. Moroianu,et al.  Nuclear import and export pathways , 1999, Journal of cellular biochemistry.

[7]  G. S. Johnson,et al.  An Information-Intensive Approach to the Molecular Pharmacology of Cancer , 1997, Science.

[8]  G. Wahl,et al.  A leucine‐rich nuclear export signal in the p53 tetramerization domain: regulation of subcellular localization and p53 activity by NES masking , 1999, The EMBO journal.

[9]  C. Maki,et al.  The MDM2 RING-finger domain is required to promote p53 nuclear export , 2000, Nature Cell Biology.

[10]  Margaret Ashcroft,et al.  Regulation of p53 stability , 1999, Oncogene.

[11]  K. Tsai,et al.  An intact HDM2 RING-finger domain is required for nuclear exclusion of p53 , 2000, Nature Cell Biology.

[12]  Dan L. Sackett,et al.  p53 is associated with cellular microtubules and is transported to the nucleus by dynein , 2000, Nature Cell Biology.

[13]  G. Demers,et al.  Loss of normal p53 function confers sensitization to Taxol by increasing G2/M arrest and apoptosis , 1996, Nature Medicine.

[14]  M V Chernov,et al.  A chemical inhibitor of p53 that protects mice from the side effects of cancer therapy. , 1999, Science.

[15]  S. Karki,et al.  Cytoplasmic dynein and dynactin in cell division and intracellular transport. , 1999, Current opinion in cell biology.

[16]  Xin-Hua Feng,et al.  Microtubule Binding to Smads May Regulate TGFβ Activity , 2000 .

[17]  A. Levine,et al.  Regulation of the p53 protein by the MDM2 oncoprotein--thirty-eighth G.H.A. Clowes Memorial Award Lecture. , 1999, Cancer research.